# Precigen

Source: https://onco.cc/companies/precigen/  
OnCo record `precigen` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Precigen is a US-based biotechnology company that leads 2 cancer trials in OnCo, testing the adenoviral immunotherapies PRGN-2012 (Papzimeos) and PRGN-2009 in rare cancers of childhood and cervical cancer.

## Summary

Precigen is a commercial-stage biopharmaceutical company developing precision medicines for difficult-to-treat diseases. Its first approved product, Papzimeos (zopapogene imadenovec, formerly PRGN-2012), is an adenoviral immunotherapy for recurrent respiratory papillomatosis; PRGN-2009 for HPV-associated cancers and the UltraCAR-T programmes are in phase 1. On ClinicalTrials.gov it is the lead sponsor of 2 trials recorded in OnCo: NCT04724980 (phase 1/2, Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis) and NCT06157151 (phase 2, PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Ce...). Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.

## Fields

- Kind: Company
- Last checked: 2026-09-17
- Also known as: Intrexon
- Tags: ctgov-sponsor
- HQ: Germantown, Maryland
- Type: biotech
- Website: https://precigen.com
- Ticker: NASDAQ:PGEN

## Sources

- Official website: https://precigen.com
- ClinicalTrials.gov: trials led by Precigen: https://clinicaltrials.gov/search?lead=Precigen%2C%20Inc

## Connected records

- cancers: [Cervical cancer](https://onco.cc/cancers/cervical/), [Rare cancers of childhood (NCI PDQ umbrella)](https://onco.cc/cancers/rare-childhood-cancers/)
- drugs: [Pembrolizumab](https://onco.cc/drugs/pembrolizumab/)
- trials: [Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis](https://onco.cc/trials/nct04724980/), [PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer](https://onco.cc/trials/nct06157151/)

---
JSON: https://onco.cc/api/v1/entities/precigen.json